Posts by: Patricia Silva, PhD

Patricia Silva, PhD

Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.

June 29, 2018July 6, 2018

Roivant Launches Altavant Sciences, a New Company Developing PAH Therapy RVT-1201

News, PAH News

Roivant recently announced the launch of two new business units, Roivant Pharma and Roivant Health, as well as the creation of Altavant Sciences, a company that will focus on developing new ... Read more

June 7, 2018June 7, 2018

Denovo Working with Stanford to Test EB102 as ‘Repurposed’ Potential Treatment for PAH and Emphysema

News, PAH News

Denovo Biopharma recently entered an exclusive global license agreement with Stanford University School of Medicine to further develop and market its lead compound, DB102 (formerly called enzastaurin), as a ... Read more

May 18, 2018May 18, 2018

Team PHenomenal Hope Provides Renewable Power to Puerto Ricans

News, PH News

The non-profit Team PHenomenal Hope is helping Puerto Ricans with pulmonary hypertension (PH) during the ongoing power outage crisis by providing portable solar panels and battery packs. The power ... Read more

April 5, 2018April 5, 2018

Phaware Association Is Working to Make World PH Day a Big Success

News, PH News

Every year, World PH Day is celebrated on May 5. This year the virtual non-profit #phaware global association is inviting friends of the pulmonary hypertension (PH) community to become ... Read more

April 2, 2018April 2, 2018

University of Virginia Pulmonary Hypertension Center Earns PHA Accreditation

News

The University of Virginia’s (UVA) Pulmonary Hypertension Center has been recognized as a Center of Comprehensive Care by the Pulmonary Hypertension Association (PHA). The PHA-accredited PH Care Centers initiative aims to ... Read more

March 16, 2018March 16, 2018

Cardiome Shares Updates on Therapies, Including Trevyent for PAH

News, PAH News

Cardiome recently shared an update on the development of its therapeutic portfolio, including Trevyent (treprostinil injection) for the treatment of pulmonary arterial hypertension (PAH). Following the U.S. Food and Drug Administration’s ... Read more

March 5, 2018March 5, 2018

Ochsner Health’s New Orleans Facility Obtains PH Association Accreditation

News, PH News

An Ochsner Health System facility in New Orleans has received Pulmonary Hypertension Association care center accreditation. The association accredits care centers that can assure patients receive top PH diagnosis and treatment. Ochsner’s PH ... Read more

February 8, 2018February 8, 2018

NYU Langone Transplant Institute Launches New Lung Transplant Program

CTEPH News, News, PH News

The NYU Langone Transplant Institute recently launched a new lung transplant program to offer lung disease patients in the New York City area an array of comprehensive services. The ... Read more

January 9, 2018January 9, 2018

Liquidia Starts Phase 3 Clinical Trial of Pulmonary Hypertension Treatment

News, PAH News

Liquidia Technologies has started a Phase 3 clinical trial to evaluate LIQ861 as a treatment for pulmonary arterial hypertension. LIQ861 is a dry-powder, inhaled formulation of treprostinil that Liquidia developed to ... Read more

January 8, 2018January 8, 2018

Bellerophon Enrolls First Patient in Phase 2b Trial of INOpulse as Treatment for ILD-linked PH

News, PH News

Bellerophon Therapeutics has enrolled the first patient in a Phase 2b clinical trial evaluating INOpulse as a treatment for pulmonary hypertension associated with interstitial lung disease, or PH-ILD. The trial (NCT03267108) ... Read more